Skin Cancer Outcomes at KFSYSCC
Between 2015-2019, the five-year survival rate for bladder cancer at KFSYSCC was 72.1% vs 70.9% for other hospitals in Taiwan.
Basic Information and Stage Distribution of 451 Skin Cancer Patients at KFSYSCC from 1990-2019
| Total | 1990-1994 | 1995-1999 | 2000-2004 | 2005-2009 | 2010-2014 | 2015-2019 | |
|---|---|---|---|---|---|---|---|
| n | 451 | 7 (2%) | 21 (5%) | 117 (26%) | 131 (29%) | 110 (24%) | 65 (14%) |
| Gender (%) | |||||||
| Male | 246 (55%) | 3 (43%) | 13 (62%) | 62 (53%) | 73 (56%) | 59 (54%) | 36 (55%) |
| Female | 205 (45%) | 4 (57%) | 8 (38%) | 55 (47%) | 58 (44%) | 51 (46%) | 29 (45%) |
| Age | |||||||
| Mean/Median | 58/60 | 61/61 | 56/62 | 58/59 | 58/60 | 56/56 | 61/62 |
| Range | 9-96 | 54-67 | 15-89 | 17-96 | 12-93 | 9-91 | 21-92 |
| Q1-Q3 | 44-70 | 57-66 | 40-72 | 44-71 | 43-74 | 42-68 | 53-76 |
| Stage (%) | |||||||
| 0 | 15 (3%) | 0 (0%) | 1 (5%) | 3 (3%) | 7 (5%) | 4 (4%) | 0 (0%) |
| I | 141 (31%) | 0 (0%) | 2 (10%) | 16 (14%) | 49 (37%) | 51 (46%) | 23 (35%) |
| II | 54 (12%) | 0 (0%) | 1 (5%) | 4 (3%) | 19 (15%) | 18 (16%) | 12 (18%) |
| III | 33 (7%) | 0 (0%) | 1 (5%) | 2 (2%) | 1 (18%) | 17 (15%) | 2 (3%) |
| IV | 24 (5%) | 2 (29%) | 1 (5%) | 6 (5%) | 6 (5%) | 4 (4%) | 5 (8%) |
| Unknown | 181 (41%) | 5 (71%) | 15 (71%) | 86 (74%) | 39 (30%) | 16 (15%) | 23 (35%) |
Based on KFSYSCC's cancer registry from 1990 to 2019, there were 451 analytic skin cancer cases, with 246 males (55%) and 205 females (45%). The average and median ages were 58 and 60 years old, respectively; the youngest patient was 9 years old, and the oldest was 96 years old; the interquartile range (Q1-Q3) was 44-70. By stage, there were 15 stage 0 skin cancer patients (3%), 141 stage I patients (31%), 54 stage II patients (12%), 33 stage III patients (7%), and 24 stage IV patients (5%). The basic information and stage distribution of all skin cancer patients, sorted by the year of diagnosis, are presented in the table above.
Survival Curves for 451 Skin Cancer Patients (1990-2019), Stratified by Year of Diagnosis
From 1990 to 2019, the chart below illustrates the five-year observed survival rates for 451 skin cancer patients at KFSYSCC, stratified by the year of diagnosis. The graph shows the five-year survival rate for skin cancer increased from 71% in 1990-1994 to 72% in 2015-2019, while the ten-year survival rate dropped from 71% in 1990-1994 to 58% in 2010-2014.
Treatment Methods and Stages for 65 Skin Cancer Patients at KFSYSCC (2015-2019)
| Category | Total | Stage I | Stage II | Stage III | Stage IV | Unknown |
|---|---|---|---|---|---|---|
| Total | 65 | 23 | 12 | 2 | 5 | 23 |
| Surgical Treatment | 60 (92%) | 23 (100%) | 12 (100%) | 2 (100%) | 0 (0%) | 23 (100%) |
| Radiation Therapy | 3 (5%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (40%) | 1 (4%) |
| Chemotherapy | 6 (9%) | 1 (4%) | 0 (0%) | 0 (0%) | 5 (100%) | 0 (0%) |
| Targeted Therapy | 1 (2%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (4%) |
| Immunotherapy | 3 (5%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (60%) | 0 (0%) |
| Palliative Care | 2 (3%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (40%) | 0 (0%) |
Between 2015 and 2019, there were a total of 65 analytic skin cancer cases, including 23 patients in stage I, 12 in stage II, 2 in stage III, and 5 in stage IV. In terms of treatment methods, 60 patients (92%) underwent surgical treatment, 3 (5%) received radiation therapy, 6 (9%) underwent chemotherapy, 1 (2%) received targeted therapy, 3 (5%) received immunotherapy, and 2 (3%) underwent palliative care.
Five-Year Survival Rates of 65 Skin Cancer Patients by Stage (2015-2019)
KFSYSCC’s 2015-2019 five-year observed survival rates for 65 skin cancer patients, stratified by stage, are presented in the chart. As shown in the graph, the five-year survival rate is 65% for stage 1, 92% for stage 2, 50% for stage 3, and 20% for stage 4.